Pharming Group N.V. - ADR

NASDAQ:PHAR 1:36:40 PM EDT

10.69

-0.31 (-2.85%)

4:04:14 PM EDT: $10.56 -0.13 (-1.22%)

Market Cap (Intraday)	706.52M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$82.63 Million
Adjusted EPS	-$0.11

See more estimates

10-Day MA	$10.85
50-Day MA	$10.14
200-Day MA	$8.97

See more pivots

Pharming Group N.V. - ADR Stock, NASDAQ:PHAR

Vondellaan 47, Leiden, Zuid-Holland 2332 AA

Netherlands

Phone: +31.71.524.74.00

Number of Employees:

http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONESTÃ?Â®, JoenjaÃ?Â®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.